Ten analysts recently shared bullish-to-bearish takes on Elevance Health over the last three months, leaning heavily bullish.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $484.4, a high estimate of $522.00, and a low estimate of $434.00. A negative shift in sentiment ...

Affiliates of UnitedHealth and other large insurers employed about 6.8% of the physicians who billed Medicare.

UnitedHealth delays Q2 report to July 29 as insurer earnings season begins with cost pressures clouding 2025 outlooks across the sector.

Elevance Health, Inc. ELV is set to report its second-quarter 2025 results on July 17, 2025, before the opening bell. The ...

Health insurance companies have pledged to improve prior authorization with 6 key reforms, according to the HHS.

Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $9.20 per share in its upcoming release, pointing to a year-over-year decline of 9.1%. It is anticipated that ...

Analysts have given Elevance Health a consensus rating of “Moderate Buy,” with twelve of sixteen recommending purchase and ...

This was the stock's third consecutive day of losses.

The percentage of payer-operated physician practices has grown significantly since 2016, according to a study published in July in Health Affairs Scholar. The study used corporate filings, mergers and ...

Elevance Health — the parent of Anthem Blue Cross and Blue Shield carriers in 14 states — is suing a Georgia company to stop ...

Elevance Health, Inc. (NYSE:ELV) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 19, Bernstein ...